logo-loader
CSE:ABRT

Albert Labs International Corp

Receive alerts
Market:
CSE
Price
0.0050 CAD
Day Change
-50.00%
Market Cap:
$372.07 k
52 weeks high
0.0050
52 weeks low
0.0050

In brief

Albert Labs International Corp is the first psychedelic company leveraging Real World Evidence Studies to enhance patient care by accelerating access to psychedelic therapy in a hospital setting for niche indications with urgent and high unmet needs. Through a collaboration with leading academic institutions, hospital networks and existing reimbursement mechanisms; Albert Labs empowers scientists, researchers, and medical professionals to accelerate safe patient treatment whilst collecting data to protect and improve its psilocybin-based medicines. Starting with cancer-related anxiety, depression and existential crisis, Albert Labs will bring psilocybin-assisted therapy to the UK and Europe before expanding globally.